Abstract: A powertrain, a control apparatus, and a motor control unit. The powertrain includes a drive motor and a transmission device. The transmission device disconnects a transmission connection between the drive motor and a wheel based on a result of a comparison between a temperature or a viscosity of a lube oil and a preset parameter value, and a rotational speed of the drive motor varies with the result of the comparison between the temperature or the viscosity of the lube oil and the preset parameter value. The drive motor stirs the lube oil through idling, to make the temperature of the lube oil rise rapidly. The powertrain, the control apparatus and the motor control unit provided can improve fluidity of the lube oil at very low temperatures, so that a lube oil pump can be started smoothly.

Abstract: A method and a system for optimization of development by carbon dioxide injection based on incomplete miscibility characteristics are provided, where the method includes following steps: building a three-dimensional reservoir model based on laboratory experiments and reservoir values, where the three-dimensional reservoir model includes: a fluid model and a reservoir model; based on the three-dimensional reservoir model, obtaining incomplete miscibility characteristics of reservoir development by carbon dioxide injection; and completing whole life cycle optimization development of carbon dioxide injection based on the incomplete miscibility characteristics.

Abstract: A method for preparing V-type granular porous starch includes the following steps: mixing starch and an ethanol aqueous solution in a temperature of 100-150° C. to yield V-type granular starch; and adding a mixed enzyme including alpha-amylase and amyloglucosidase to a mixture of the V-type granular starch and the ethanol aqueous solution, to enzymatically hydrolyze the V-type granular starch to yield V-type granular porous starch.

Abstract: A method and a system for optimization of development by carbon dioxide injection based on incomplete miscibility characteristics are provided, where the method includes following steps: building a three-dimensional reservoir model based on laboratory experiments and reservoir values, where the three-dimensional reservoir model includes: a fluid model and a reservoir model; based on the three-dimensional reservoir model, obtaining incomplete miscibility characteristics of reservoir development by carbon dioxide injection; and completing whole life cycle optimization development of carbon dioxide injection based on the incomplete miscibility characteristics.

Abstract: A sound collecting system includes a first electronic device, a left-ear TWS earphone, and a right-ear TWS earphone. Microphones of the first electronic device, the left-ear TWS earphone, and the right-ear TWS earphone form a first microphone array. When the first electronic device detects a user operation of starting video recording, the first microphone array performs sound collecting to obtain a joint microphone array signal. The first electronic device performs noise reduction processing on the joint microphone array signal.

Abstract: A compound of Formula I compound—Ovatodiolide which is safe and effective to use in a pharmaceutical composition for inhibition of SARS-CoV-2 is provided. The pharmaceutical composition comprising a safe and effective amount of a compound of Formula I compound—Ovatodiolide or pharmaceutically acceptable salts thereof, together with a pharmaceutically acceptable carrier, which has great potential to treat SARS-CoV-2 induced COVID-19 based on a safe and effective amount of a compound of Formula I compound—Ovatodiolide.

Abstract: A shield cooling assembly includes an adapter configured to fix a shield in the chamber. The adapter includes a first surface and a second surface facing an outer side surface of the shield and a bottom surface of a bottom wall of the shield, respectively. A predetermined gap is provided between the first surface and the outer side surface of the shield. The second surface is in contact with the bottom surface of the bottom wall of the shield. The adapter is provided with a cooling channel for transmitting a cooling medium to cool the shield.

Abstract: The present disclosure provides a carrying device and a semiconductor processing apparatus. The carrying device includes a heating plate and a cooling plate, the heating plate and the cooling plate are spaced apart, and a thermal insulation region is formed between the heating plate and the cooling plate. The carrying device of the present disclosure not only can preempt the need to stop the process due to excessively high temperature, but also can maintain a uniform and stable temperature throughout the process, thereby providing a qualified and stable processing temperature for a workpiece to be processed, and eventually obtaining better processing results.

Abstract: An audio processing method includes establishing a wireless connection between a wireless headset and an electronic device, and establishing a wireless connection between the wireless headset and a charging case. The charging case collects a sound signal, generates first audio data, and sends the first audio data to the wireless headset. The wireless headset performs audio effect processing on the first audio data to obtain second audio data. The electronic device sends third audio data to the wireless headset. The wireless headset performs audio mixing processing on the second audio data and the third audio data to obtain fourth audio data and plays the fourth audio data.

Abstract: The present invention relates to a use of a natural compound Anisomelic acid extracted from Anisomeles indica O. Kuntze in the preparation of pharmaceutical compositions for inhibiting the infection and replication of novel coronaviruses and the mutant strains (SARS-CoV-2 variants) thereof, the Anisomelic acid is a compound comprising a chemical structural Formula I, the pharmaceutical composition includes a safe and effective amount of Anisomelic acid, that is, the pharmaceutical composition is a combination of a safe and effective amount of Anisomelic acid and its pharmaceutically acceptable salt or carrier thereof.

Abstract: The present disclosure relates to reagents and their use for elemental imaging mass spectrometry of biological samples.

Abstract: A powertrain, a control apparatus, and a motor control unit. The powertrain includes a drive motor and a transmission device. The transmission device disconnects a transmission connection between the drive motor and a wheel based on a result of a comparison between a temperature or a viscosity of a lube oil and a preset parameter value, and a rotational speed of the drive motor varies with the result of the comparison between the temperature or the viscosity of the lube oil and the preset parameter value. The drive motor stirs the lube oil through idling, to make the temperature of the lube oil rise rapidly. The powertrain, the control apparatus and the motor control unit provided can improve fluidity of the lube oil at very low temperatures, so that a lube oil pump can be started smoothly.

Abstract: Described herein are systems, methods, and software to manage the identification of control packets in an encapsulation header. In one implementation, a computing system may receive a Geneve packet at a network interface and determine that the Geneve packet includes an Operations and Management (OAM) flag. Once the OAM flag is identified, the computing system can select a processing queue from a plurality of processing queues for a main processing system of the computing system based on the OAM flag and assign the Geneve packet to the processing queue.

Abstract: In one embodiment, a method of building an optimized color flow high parameter reagent 20-color panel for detection of aberrant cells in acute myeloid leukemia (AML) is disclosed using a full spectrum flow cytometer. In another embodiment, a reagent kit for detection of aberrant cells in acute myeloid leukemia (AML) is disclosed for use with a full spectrum flow cytometer.

Abstract: This application discloses a sound collecting method, an electronic device, and a system. The system includes a first electronic device, a left-ear TWS earphone, and a right-ear TWS earphone. In the method, microphones of the first electronic device, the left-ear TWS earphone, and the right-ear TWS earphone may form a first microphone array. When the first electronic device detects a user operation of starting video recording, the first microphone array performs sound collecting to obtain a joint microphone array signal. The first electronic device may perform noise reduction processing on the joint microphone array signal. According to the method, in a near field area of the first microphone array, a target sound signal can be enhanced, an ambient noise sound signal can be suppressed, and sound quality in a recorded video can be improved.

Abstract: An electronic expansion valve includes a valve seat assembly, a first pipe connecting portion, and a second pipe connecting portion. The valve seat assembly includes an outer wall portion, a valve port portion having a valve port, a first valve seat cavity, and a second valve seat cavity. The first valve seat cavity is located above the valve port portion. The second valve seat cavity is located below the valve port portion. The valve port is capable of communicating with the first valve seat cavity and the second valve seat cavity. The first pipe connecting portion is fixedly connected to the outer wall portion located above the valve port portion. The second pipe connecting portion is fixedly connected to the outer wall portion located below the valve port portion. The inner diameter of the second valve seat cavity is greater than the inner diameter of the second pipe connecting portion.

Abstract: In one embodiment, a method of building an optimized color flow high parameter reagent and reagent kit cytometry panel for detection of aberrant cells in acute myeloid leukemia is disclosed using a spectral flow cytometer with a least three excitation lasers and thirty-eight color detectors. In another embodiment, a graphical user interface is disclosed generated by a server computer from a fluorochrome database and displayed by a client computer to assist in the selection of a set of fluorochromes for use in an assay to analyze biological samples. The GUI can display spectra graphs to visually show how fluorochromes may overlap and can generate similarity indexes for the paired fluorochrome interference and a complexity index for overall many to many interferences generated by a selected group or set of fluorochromes.

Abstract: Described herein are systems, methods, and software to manage the identification of control packets in an encapsulation header. In one implementation, a computing system may receive a Geneve packet at a network interface and determine that the Geneve packet includes an Operations and Management (OAM) flag. Once the OAM flag is identified, the computing system can select a processing queue from a plurality of processing queues for a main processing system of the computing system based on the OAM flag and assign the Geneve packet to the processing queue.

Abstract: One embodiment provides an electrical key for locking and unlocking an electrical lock. The electrical key includes an energy-transfer unit that includes a magnetic core and a coil wrapped around the magnetic core, a pulse generator configured to generate a first pulse sequence including alternating pulse on and pulse off cycles and a second pulse sequence comprising a continuous pulse train, and a modulator driver configured to modulate a voltage or current on the coil using the generated first or second pulse sequence, a measurement module configured to measure a current or voltage on the coil excited by the modulated voltage or current, respectively, a key-position determination module configured to determine a relative position between the electrical key and the electrical lock based on the measured current or voltage, and a communication interface for communicating with the electrical lock to facilitate the locking and unlocking of the electrical lock.

Abstract: A compound of Formula I compound—Ovatodiolide which is safe and effective to use in a pharmaceutical composition for inhibition of SARS-CoV-2 is provided. The pharmaceutical composition comprising a safe and effective amount of a compound of Formula I compound—Ovatodiolide or pharmaceutically acceptable salts thereof, together with a pharmaceutically acceptable carrier, which has great potential to treat SARS-CoV-2 induced COVID-19 based on a safe and effective amount of a compound of Formula I compound—Ovatodiolide.